Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Other Non-Current Assets: 2021-2025

Historic Other Non-Current Assets for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $32.9 million.

  • Roivant Sciences' Other Non-Current Assets fell 91.31% to $27.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.8 million, marking a year-over-year decrease of 91.31%. This contributed to the annual value of $32.9 million for FY2025, which is 78.97% down from last year.
  • Per Roivant Sciences' latest filing, its Other Non-Current Assets stood at $32.9 million for FY2025, which was down 3.01% from $33.9 million recorded in FY2024.
  • Roivant Sciences' Other Non-Current Assets' 5-year high stood at $156.3 million during FY2024, with a 5-year trough of $20.9 million in FY2021.
  • Moreover, its 3-year median value for Other Non-Current Assets was $46.8 million (2023), whereas its average is $63.9 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 215.81% in 2024, then tumbled by 78.97% in 2025.
  • Roivant Sciences' Other Non-Current Assets (Yearly) stood at $86.6 million in 2021, then reached $20.9 million in 2021, then slumped by 70.19% to $25.8 million in 2022, then spiked by 121.43% to $46.2 million in 2022, then spiked by 91.62% to $49.5 million in 2023, then grew by 1.35% to $46.8 million in 2023, then spiked by 215.81% to $156.3 million in 2024, then decreased by 27.68% to $33.9 million in 2024, then tumbled by 78.97% to $32.9 million in 2025.